7-[(2-aminocyclohexyl)amino]-5-(1-methylpyrazol-4-yl)-2,3-dihydropyrimido[5,4-e][1,3]oxazin-4-one
C16H21N7O2 — CID 123910473
Data last refreshed: (MolForge compound catalog, from PubChem)
About 7-[(2-aminocyclohexyl)amino]-5-(1-methylpyrazol-4-yl)-2,3-dihydropyrimido[5,4-e][1,3]oxazin-4-one
7-[(2-aminocyclohexyl)amino]-5-(1-methylpyrazol-4-yl)-2,3-dihydropyrimido[5,4-e][1,3]oxazin-4-one (PubChem CID 123910473) has the molecular formula C16H21N7O2 and a molecular weight of 343.39 g/mol. Its IUPAC name is 7-[(2-aminocyclohexyl)amino]-5-(1-methylpyrazol-4-yl)-2,3-dihydropyrimido[5,4-e][1,3]oxazin-4-one.
Molecular Properties
| Compound Name | 7-[(2-aminocyclohexyl)amino]-5-(1-methylpyrazol-4-yl)-2,3-dihydropyrimido[5,4-e][1,3]oxazin-4-one |
|---|---|
| PubChem CID | 123910473 |
| Molecular Formula | C16H21N7O2 |
| Molecular Weight | 343.39 g/mol |
| Exact Mass | 343.18 |
| IUPAC Name | 7-[(2-aminocyclohexyl)amino]-5-(1-methylpyrazol-4-yl)-2,3-dihydropyrimido[5,4-e][1,3]oxazin-4-one |
| SMILES | Cn1cc(-c2nc(NC3CCCCC3N)nc3c2C(=O)NCO3)cn1 |
| InChI | InChI=1S/C16H21N7O2/c1-23-7-9(6-19-23)13-12-14(24)18-8-25-15(12)22-16(21-13)20-11-5-3-2-4-10(11)17/h6-7,10-11H,2-5,8,17H2,1H3,(H,18,24)(H,20,21,22) |
| InChIKey | XIXIHDAKVARUJW-UHFFFAOYSA-N |
| XLogP | 0.64 |
| TPSA | 119.98 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 343.39 |
| LogP ≤ 5 | 0.64 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123910473 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.